U.S. Stock Market Midday Update

Venus Concept, down 14.29%, with increased trading volume and no significant news recently. The trading is active, with clear capital flow. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation.

Stocks with High Trading Volume in the Industry

Abbott down 1.38%, with increased trading volume. Based on recent key news:

1. On January 26, Abbott CEO Robert Ford increased his stake in the company, showing confidence in its future. Ford purchased over $2 million worth of stock, and the market reacted positively, leading to a short-term rebound in the stock price.

2. On January 27, analysts held an optimistic view on Abbott's long-term prospects, despite pressures in its nutrition and diagnostics businesses. Analysts believe the company's core business is strong and expect steady growth by 2026, which supports the stock price.

3. On January 27, Abbott raised its revenue growth forecast for 2026 to 6.5% to 7.5% and plans to acquire Exact Sciences to expand its business scope. This move is seen as part of the company's strategic expansion and may drive the stock price up. The healthcare industry faces short-term pressures but has significant long-term growth potential.

ENvue Medical up 144.52%. Based on recent news,

1. On January 28, ENvue Medical announced that its ENFit syringes are available for sale on the U-Deliver website, Amazon store, and wholesale channels without a prescription. This news significantly boosted the stock price.

2. On January 28, ENvue Medical's trading volume surged to 11.05 million shares, compared to an average trading volume of 1.36 million shares, indicating strong market interest in the stock.

3. On January 28, ENvue Medical's stock price rose 20.124% in pre-market trading, reaching $1.26, reflecting investors' optimistic expectations for the company's prospects. The medical device industry has performed strongly recently, with robust market demand.

Boston Scientific up 0.46%. Based on recent key news:

1. On January 26, EVERCORE included Boston Scientific in its tactical outperform list, boosting market confidence and driving the stock price up. Source: Zhitong Finance

2. On January 27, analysts rated Boston Scientific as a moderate buy, showing some market support despite better investment options. Source: Wall Street Insights

3. On January 28, Boston Scientific's P/E ratio data indicates its growth potential in the medical device sector, attracting investor attention. Source: Yahoo Finance The medical device industry shows significant growth potential.

Stocks with High Market Capitalization in the Industry Intuitive Surgical fell 0.41%, with increased trading volume. Based on recent key news:

1. On January 26, the FDA approved the da Vinci surgical system for cardiac surgery, expanding its application range. This regulatory approval enhances the system's market potential and may drive future surgical volume growth.

2. On January 26, China Merchants Securities initiated coverage on Intuitive Surgical with an "Overweight" rating and a target price of $613. The report pointed out that the upgrade of the da Vinci surgical system and the growth in surgical volume are the main drivers of the company's future growth.

3. On January 23, Barclays analysts maintained a "Buy" rating on Intuitive Surgical with a target price of $712. Analysts are optimistic about the company's leading position in the surgical robotics field. The market penetration of surgical robots is increasing, providing significant growth potential